[1]
2026. Active Targeting Design and Preclinical Progress of Liposome-Based Nanocarriers for Cancer Therapy. Highlights in Science, Engineering and Technology. 162, (Apr. 2026), 327–332. DOI:https://doi.org/10.54097/9911t393.